This study aimed to evaluate the association between NOS2/ARG1 expression and systemic immune cell ratios with local tumor immune infiltrates (TILs, TAMs) and to assess their prognostic significance for response to cetuximab-based chemotherapy and patient survival. This evidence concerns the gene ARG1 and neoplasm.